Cost-effectiveness of albumin in the treatment of decompensated cirrhosis in resource-limited healthcare settings

Irsan Hasan, Ignatia Sinta Murti, Putut Bayupurnama, Kemal Fariz Kalista, Christina Hill-Zabala, Dennis Kananda, Elisabet Viayna

Article Type

Original Research

Published

This study aims to assess the cost-effectiveness of human albumin in patients with cirrhosis with spontaneous bacterial peritonitis, hepatorenal syndrome or ascites requiring large-volume paracentesis in the Indonesian healthcare system as a representative of a resource-limited setting.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.